| G-CSF in the treatment of acute myeloid leukemia: is it safe? | |
| | |
MedLine Citation:
|
PMID: 7510194 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recent studies of granulocyte colony stimulating factor (G-CSF) in the treatment of myeloid leukemia in Japan have revealed that: 1) G-CSF accelerates neutrophil recovery significantly after intensive chemotherapy or bone marrow transplantation (BMT); 2) G-CSF decreases the number of febrile days and the incidence of documented infections; 3) daily administration of G-CSF, starting from two days before chemotherapy or starting from two days after the end of chemotherapy, tended to increase the remission rate; 4) there is no evidence of stimulation by G-CSF of the growth of myeloid leukemia cells if it is used for a short period of time and if the number of leukemic cells is highly reduced by chemotherapy; 5) there is no evidence that G-CSF administration increases relapse rates of leukemia after chemotherapy or BMT. However, until further randomized studies answer these questions, caution must be exercised to avoid unnecessary stimulation of neutrophil production, and G-CSF should not be given to myeloid leukemia patients with a large number of leukemic cells left. |
| | |
Authors:
|
R Ohno |
Related Documents
:
|
9053494 - Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in ... 23643694 - Late recurrence in melanoma: clinical implications of lost dormancy. 20976544 - Chemotherapy characteristics are important predictors of primary prophylactic csf admin... 16207534 - Neutropenia management with granulocyte colony-stimulating factors: from guidelines to ... 172214 - Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-... 2039324 - Bronchogenic carcinoma with chest wall invasion. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Leukemia & lymphoma Volume: 11 Suppl 2 ISSN: 1042-8194 ISO Abbreviation: Leuk. Lymphoma Publication Date: 1993 |
Date Detail:
|
Created Date: 1994-04-13 Completed Date: 1994-04-13 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9007422 Medline TA: Leuk Lymphoma Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 15-9 Citation Subset: IM |
Affiliation:
|
Department of Medicine III, Hamamatsu University School of Medicine, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bone Marrow Transplantation Clinical Trials as Topic Granulocyte Colony-Stimulating Factor / administration & dosage, therapeutic use* Humans Leukemia, Myeloid, Acute / therapy* |
| Chemical | |
Reg. No./Substance:
|
143011-72-7/Granulocyte Colony-Stimulating Factor |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prevention of chemotherapy-induced neutropenia using G-CSF with VACOP-B--a case report.
Next Document: Distribution of alpha-galactosyl-containing epitopes on Trypanosoma cruzi trypomastigote and amastig...